Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:1475-1479, doi:10.1016/S0735-1097(03)00187-6
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akosah, K. O.
Right arrow Articles by Schoenfeld, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akosah, K. O.
Right arrow Articles by Schoenfeld, P.

CLINICAL STUDY

Preventing myocardial infarction in the young adult in the first place: how do the national cholesterol education panel iii guidelines perform?

Kwame O. Akosah, MD*,*, Ana Schaper, PhD*, Christopher Cogbill, BA* and Paul Schoenfeld, MD*

* Gundersen Lutheran Medical Foundation, La Crosse, Wisconsin, USA

Manuscript received April 23, 2002; revised manuscript received November 7, 2002, accepted January 9, 2003.

* Reprint requests and correspondence: Dr. Kwame O. Akosah, Gundersen Lutheran Medical Foundation, 1836 South Avenue, La Crosse, Wisconsin 54601, USA.
koakosah{at}gundluth.org

OBJECTIVES: The purpose of this study was to investigate the utility of the new National Cholesterol Education Program (NCEP) III guidelines in a group of young adults.

BACKGROUND: These guidelines have been hailed as an improvement in their potential to identify individuals at risk for coronary heart disease (CHD) complications. Compared with the NCEP II, the new guidelines will increase the number of patients who qualify for medical management. However, the effectiveness of these guidelines to identify young adults at risk for a cardiac event is yet to be studied.

METHODS: A retrospective review of clinical data from young adults (age ≤55 years for men and ≤65 years for women) hospitalized for acute myocardial infarction over a three-year period was conducted. Patients with a history of CHD or CHD equivalent were excluded. Using the NCEP III guidelines, we calculated a 10-year risk for coronary events on all patients.

RESULTS: A total of 222 patients met criteria for inclusion. The mean age was 50 years and 25% were women. Mean lipid levels were all within the normal range; however, rates of smoking and obesity were high. When the 10-year risk of these patients was stratified by the number of risk factors and low-density lipoprotein cholesterol level, only 25% met criteria to qualify for pharmacotherapy. For women in this population, only 18% met criteria for treatment.

CONCLUSIONS: The new guidelines offer multiple new features but have a tendency to underappreciate the risk for disease in young adults. To improve performance in young adults, statistical adjustments may be necessary.

Abbreviations and Acronyms
  BMI = body mass index
  CHD = coronary heart disease
  HDL = high-density lipoprotein
  LDL = low-density lipoprotein
  MI = myocardial infarction
  NCEP = National Cholesterol Education Program




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
G. Guaraldi and I. G. Baraboutis
Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities
J. Antimicrob. Chemother., September 1, 2009; 64(3): 437 - 440.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. D. Michos and R. S. Blumenthal
Prevalence of low low-density lipoprotein cholesterol with elevated high sensitivity C-reactive protein in the U.S.: implications of the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) study.
J. Am. Coll. Cardiol., March 17, 2009; 53(11): 931 - 935.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
P. Kaul and P. S. Douglas
Atherosclerosis Imaging: Prognostically Useful or Merely More of What We Know?
Circ Cardiovasc Imaging, March 1, 2009; 2(2): 150 - 160.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. P. Carrigan, D. Nair, P. Schoenhagen, R. J. Curtin, Z. B. Popovic, S. Halliburton, S. Kuzmiak, R. D. White, S. D. Flamm, and M. Y. Desai
Prognostic utility of 64-slice computed tomography in patients with suspected but no documented coronary artery disease
Eur. Heart J., February 1, 2009; 30(3): 362 - 371.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. M. Johnson, D. A. Dowe, and J. A. Brink
Traditional Clinical Risk Assessment Tools Do Not Accurately Predict Coronary Atherosclerotic Plaque Burden: A CT Angiography Study
Am. J. Roentgenol., January 1, 2009; 192(1): 235 - 243.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E.-K. Choi, S. I. Choi, J. J. Rivera, K. Nasir, S.-A. Chang, E. J. Chun, H.-K. Kim, D.-J. Choi, R. S. Blumenthal, and H.-J. Chang
Coronary Computed Tomography Angiography as a Screening Tool for the Detection of Occult Coronary Artery Disease in Asymptomatic Individuals
J. Am. Coll. Cardiol., July 29, 2008; 52(5): 357 - 365.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. M. Luke, J. P. Kane, D. M. Liu, C. M. Rowland, D. Shiffman, J. Cassano, J. J. Catanese, C. R. Pullinger, D. U. Leong, A. R. Arellano, et al.
A Polymorphism in the Protease-Like Domain of Apolipoprotein(a) Is Associated With Severe Coronary Artery Disease
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2030 - 2036.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]


Home page
JAMAHome page
R. S. Blumenthal, E. D. Michos, and K. Nasir
Further Improvements in CHD Risk Prediction for Women
JAMA, February 14, 2007; 297(6): 641 - 643.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]


Home page
Diabetes and Vascular Disease ResearchHome page
S. Zarich, C. Luciano, J. Hulford, and A. Abdullah
Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population?
Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 103 - 107.
[Abstract] [PDF]


Home page
LupusHome page
C P Chung, A Oeser, I Avalos, P Raggi, and C M Stein
Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus
Lupus, September 1, 2006; 15(9): 562 - 569.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Shiffman, C. M. Rowland, J. Z. Louie, M. M. Luke, L. A. Bare, J. I. Bolonick, B. A. Young, J. J. Catanese, C. F. Stiggins, C. R. Pullinger, et al.
Gene Variants of VAMP8 and HNRPUL1 Are Associated With Early-Onset Myocardial Infarction
Arterioscler Thromb Vasc Biol, July 1, 2006; 26(7): 1613 - 1618.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Clouse, J. Chen, H. M. Krumholz, M. E. Clouse, J. Chen, and H. M. Krumholz
Noninvasive Screening for Coronary Artery Disease With Computed Tomography Is Useful
Circulation, January 3, 2006; 113(1): 125 - 146.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Nasir, E. D. Michos, R. S. Blumenthal, and P. Raggi
Detection of High-Risk Young Adults and Women by Coronary Calcium and National Cholesterol Education Program Panel III Guidelines
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1931 - 1936.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. L. Anderson and J. F. Carlquist
Cytokines, Interleukin-18, and the Genetic Determinants of Vascular Inflammation
Circulation, August 2, 2005; 112(5): 620 - 623.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. H. O'Keefe Jr, L. Cordain, W. H. Harris, R. M. Moe, and R. Vogel
Optimal low-density lipoprotein is 50 to 70 mg/dl: Lower is better and physiologically normal
J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2142 - 2146.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement